First Quadrant’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-99
Closed -$8K 636
2020
Q2
$8K Buy
+99
New +$7.88K ﹤0.01% 696
2019
Q2
Sell
-1,538
Closed -$155K 709
2019
Q1
$155K Buy
+1,538
New +$137K 0.01% 529
2018
Q3
Sell
-35,457
Closed -$3.84M 847
2018
Q2
$3.84M Hold
35,457
0.07% 257
2018
Q1
$3.69M Buy
+35,457
New +$4.12M 0.07% 256
2016
Q3
Sell
-218,400
Closed -$23.3M 871
2016
Q2
$23.3M Buy
218,400
+6,836
+3% +$705K 0.51% 53
2016
Q1
$22.3M Buy
211,564
+36,897
+21% +$3.54M 0.49% 62
2015
Q4
$15.6M Buy
+174,667
New +$15.6M 0.34% 94
2015
Q3
Sell
-231,100
Closed -$24.6M 803
2015
Q2
$24.6M Buy
+231,100
New +$23.2M 0.52% 58

Other funds holding CRI

First Quadrant's CRI Position: Q3 2020 in Review

First Quadrant sold out of Carter's (CRI) in Q3 2020, closing a stake of 99 shares — an estimated $8K sold.

First Quadrant first reported a position in CRI in Q2 2015 and held it in 8 quarters. The position peaked at $24.6M in Q2 2015. 284 funds tracked by Wall St. Rank hold CRI as of Q3 2020.

  • First Quadrant reported no remaining Carter's position as of Q3 2020 after selling out during the quarter.
  • First Quadrant sold 99 Carter's shares in Q3 2020, an estimated $8K.
  • First Quadrant first reported a position in Carter's in Q2 2015 and held it in 8 quarters.
  • First Quadrant's Carter's position peaked at $24.6M in Q2 2015.
  • 284 funds tracked by Wall St. Rank held Carter's as of Q3 2020.

Based on First Quadrant's 13F filing for Q3 2020, filed 28 Oct 2020.